Terms: = Bone cancer AND MUC16, CA125, CA-125 AND Treatment
42 results:
1. Successful pregnancy via in vitro fertilization in a primary infertile woman with primary lymphoma of the fallopian tube after surgery: A case report and literature review.
Zhang J; Hou Z; Huang J; Xu W; Wang C; Ma X; Lu N; Liu J; Mao Y; Qian Y
Medicine (Baltimore); 2022 Jul; 101(30):e29353. PubMed ID: 35905233
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract] [Full Text] [Related]
3. treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review.
Yang Q; Han E; Xu S; Xu Y; Gao J
Hemodial Int; 2022 Jul; 26(3):E31-E36. PubMed ID: 35583084
[TBL] [Abstract] [Full Text] [Related]
4. Application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance.
Li H; Wang M; Zhu Z; Lu Y
BMC Med Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983423
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian cancer Patients.
Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH
Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366
[TBL] [Abstract] [Full Text] [Related]
6. Multidisciplinary Clinical Considerations in the treatment of Pediatric Epithelial Ovarian cancer.
Pennesi CM; Rosen MW; McIlwain CA; Newman EA; Reynolds RK; Quint EH
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):893-895. PubMed ID: 34062234
[TBL] [Abstract] [Full Text] [Related]
7. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
[TBL] [Abstract] [Full Text] [Related]
8. Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.
Chen HJ; Tu CY; Huang KY; Chien CR; Hsia TC
PLoS One; 2020; 15(12):e0240736. PubMed ID: 33306683
[TBL] [Abstract] [Full Text] [Related]
9. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract] [Full Text] [Related]
10. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract] [Full Text] [Related]
11. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract] [Full Text] [Related]
12. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract] [Full Text] [Related]
13. Chemotherapy Toxicity in
Weitzner O; Yagur Y; Kadan Y; Beiner ME; Fishman A; Ben Ezry E; Amitai Komem D; Helpman L
Oncologist; 2019 Dec; 24(12):e1471-e1475. PubMed ID: 31346131
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis.
Zang S; He Q; Bao Q; Shen Y; Zhang W
Int J Clin Oncol; 2019 Sep; 24(9):1049-1060. PubMed ID: 31028506
[TBL] [Abstract] [Full Text] [Related]
15. Surgical treatment of Metastatic Ovarian Tumors From Extragenital Primary Sites.
Sal V; Demirkiran F; Topuz S; Kahramanoglu I; Yalcin I; Bese T; Sozen H; Tokgozoglu N; Salihoglu Y; Turan H; Iyibozkurt C; Kolomuc T; Sofiyeva N; Berkman S; Arvas M
Int J Gynecol Cancer; 2016 May; 26(4):688-96. PubMed ID: 26937750
[TBL] [Abstract] [Full Text] [Related]
16. Surveillance and Care of the Gynecologic cancer Survivor.
Faubion SS; MacLaughlin KL; Long ME; Pruthi S; Casey PM
J Womens Health (Larchmt); 2015 Nov; 24(11):899-906. PubMed ID: 26208166
[TBL] [Abstract] [Full Text] [Related]
17. The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis.
Dong Y; Hou H; Wang C; Li J; Yao Q; Amer S; Tian M
Biomed Res Int; 2015; 2015():489021. PubMed ID: 25879025
[TBL] [Abstract] [Full Text] [Related]
18. Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.
Mou W; Liu Z; Luo Y; Zou M; Ren C; Zhang C; Wen X; Wang Y; Tian Y
Med Oncol; 2014 Sep; 31(9):59. PubMed ID: 25119500
[TBL] [Abstract] [Full Text] [Related]
19. Intraperitoneal chemotherapy for peritoneal carcinomatosis improves efficacy with acceptable safety: results of 200 cycles for 41 patients.
Liu Y; Yang T; Huang CQ; Li G; Li Y
Hepatogastroenterology; 2014; 61(130):373-8. PubMed ID: 24901143
[TBL] [Abstract] [Full Text] [Related]
20. Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.
Chapman JS; Powell CB; McLennan J; Crawford B; Mak J; Stewart N; Chen LM
Gynecol Oncol; 2011 Aug; 122(2):339-43. PubMed ID: 21531449
[TBL] [Abstract] [Full Text] [Related]
[Next]
